Home Newsletters Prostate Cell News Acetylation of KLF5 Maintains EMT and Tumorigenicity to Cause Chemoresistant Bone Metastasis...

Acetylation of KLF5 Maintains EMT and Tumorigenicity to Cause Chemoresistant Bone Metastasis in Prostate Cancer

0
Investigators report that bone-borne TGF-β induced the acetylation of transcription factor KLF5 in prostate cancer bone metastases, and acetylated KLF5 caused osteoclastogenesis and bone metastatic lesions by activating CXCR4, which led to IL-11 secretion, and stimulated SHH/IL-6 paracrine signaling.
[Nature Communications]
6807162 {6807162:G35EE5ZE} apa 50 1 160226 https://www.stemcellsciencenews.com/wp-content/plugins/zotpress/
%7B%22status%22%3A%22success%22%2C%22updateneeded%22%3Afalse%2C%22instance%22%3A%22zotpress-131c7a89036d80cdf10a2dd179c68d18%22%2C%22meta%22%3A%7B%22request_last%22%3A0%2C%22request_next%22%3A0%2C%22used_cache%22%3Atrue%7D%2C%22data%22%3A%5B%7B%22key%22%3A%22G35EE5ZE%22%2C%22library%22%3A%7B%22id%22%3A6807162%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Zhang%20et%20al.%22%2C%22parsedDate%22%3A%222021-03-17%22%2C%22numChildren%22%3A2%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%3EZhang%2C%20B.%2C%20Li%2C%20Y.%2C%20Wu%2C%20Q.%2C%20Xie%2C%20L.%2C%20Barwick%2C%20B.%2C%20Fu%2C%20C.%2C%20Li%2C%20X.%2C%20Wu%2C%20D.%2C%20Xia%2C%20S.%2C%20Chen%2C%20J.%2C%20Qian%2C%20W.%20P.%2C%20Yang%2C%20L.%2C%20Osunkoya%2C%20A.%20O.%2C%20Boise%2C%20L.%2C%20Vertino%2C%20P.%20M.%2C%20Zhao%2C%20Y.%2C%20Li%2C%20M.%2C%20Chen%2C%20H.-R.%2C%20Kowalski%2C%20J.%2C%20%26%23x2026%3B%20Dong%2C%20J.-T.%20%282021%29.%20Acetylation%20of%20KLF5%20maintains%20EMT%20and%20tumorigenicity%20to%20cause%20chemoresistant%20bone%20metastasis%20in%20prostate%20cancer.%20%3Ci%3ENature%20Communications%3C%5C%2Fi%3E%2C%20%3Ci%3E12%3C%5C%2Fi%3E%281%29%2C%201714.%20%3Ca%20href%3D%27https%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1038%5C%2Fs41467-021-21976-w%27%3Ehttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1038%5C%2Fs41467-021-21976-w%3C%5C%2Fa%3E%20%3Ca%20title%3D%27Cite%20in%20RIS%20Format%27%20class%3D%27zp-CiteRIS%27%20href%3D%27https%3A%5C%2F%5C%2Fwww.stemcellsciencenews.com%5C%2Fwp-content%5C%2Fplugins%5C%2Fzotpress%5C%2Flib%5C%2Frequest%5C%2Frequest.cite.php%3Fapi_user_id%3D6807162%26amp%3Bitem_key%3DG35EE5ZE%27%3ECite%3C%5C%2Fa%3E%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Acetylation%20of%20KLF5%20maintains%20EMT%20and%20tumorigenicity%20to%20cause%20chemoresistant%20bone%20metastasis%20in%20prostate%20cancer%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Baotong%22%2C%22lastName%22%3A%22Zhang%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Yixiang%22%2C%22lastName%22%3A%22Li%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Qiao%22%2C%22lastName%22%3A%22Wu%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Lin%22%2C%22lastName%22%3A%22Xie%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Benjamin%22%2C%22lastName%22%3A%22Barwick%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Changying%22%2C%22lastName%22%3A%22Fu%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Xin%22%2C%22lastName%22%3A%22Li%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Daqing%22%2C%22lastName%22%3A%22Wu%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Siyuan%22%2C%22lastName%22%3A%22Xia%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jing%22%2C%22lastName%22%3A%22Chen%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Wei%20Ping%22%2C%22lastName%22%3A%22Qian%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Lily%22%2C%22lastName%22%3A%22Yang%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Adeboye%20O.%22%2C%22lastName%22%3A%22Osunkoya%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Lawrence%22%2C%22lastName%22%3A%22Boise%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Paula%20M.%22%2C%22lastName%22%3A%22Vertino%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Yichao%22%2C%22lastName%22%3A%22Zhao%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Menglin%22%2C%22lastName%22%3A%22Li%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Hsiao-Rong%22%2C%22lastName%22%3A%22Chen%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jeanne%22%2C%22lastName%22%3A%22Kowalski%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Omer%22%2C%22lastName%22%3A%22Kucuk%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Wei%22%2C%22lastName%22%3A%22Zhou%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jin-Tang%22%2C%22lastName%22%3A%22Dong%22%7D%5D%2C%22abstractNote%22%3A%22Advanced%20prostate%20cancer%20%28PCa%29%20often%20develops%20bone%20metastasis%2C%20for%20which%20therapies%20are%20very%20limited%20and%20the%20underlying%20mechanisms%20are%20poorly%20understood.%20We%20report%20that%20bone-borne%20TGF-%5Cu03b2%20induces%20the%20acetylation%20of%20transcription%20factor%20KLF5%20in%20PCa%20bone%20metastases%2C%20and%20acetylated%20KLF5%20%28Ac-KLF5%29%20causes%20osteoclastogenesis%20and%20bone%20metastatic%20lesions%20by%20activating%20CXCR4%2C%20which%20leads%20to%20IL-11%20secretion%2C%20and%20stimulating%20SHH%5C%2FIL-6%20paracrine%20signaling.%20While%20essential%20for%20maintaining%20the%20mesenchymal%20phenotype%20and%20tumorigenicity%2C%20Ac-KLF5%20also%20causes%20resistance%20to%20docetaxel%20in%20tumors%20and%20bone%20metastases%2C%20which%20is%20overcome%20by%20targeting%20CXCR4%20with%20FDA-approved%20plerixafor.%20Establishing%20a%20mechanism%20for%20bone%20metastasis%20and%20chemoresistance%20in%20PCa%2C%20these%20findings%20provide%20a%20rationale%20for%20treating%20chemoresistant%20bone%20metastasis%20of%20PCa%20with%20inhibitors%20of%20Ac-KLF5%5C%2FCXCR4%20signaling.%22%2C%22date%22%3A%222021-03-17%22%2C%22language%22%3A%22en%22%2C%22DOI%22%3A%2210.1038%5C%2Fs41467-021-21976-w%22%2C%22ISSN%22%3A%222041-1723%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Fwww.nature.com%5C%2Farticles%5C%2Fs41467-021-21976-w%22%2C%22collections%22%3A%5B%5D%2C%22dateModified%22%3A%222021-03-17T21%3A06%3A57Z%22%7D%7D%5D%7D
Zhang, B., Li, Y., Wu, Q., Xie, L., Barwick, B., Fu, C., Li, X., Wu, D., Xia, S., Chen, J., Qian, W. P., Yang, L., Osunkoya, A. O., Boise, L., Vertino, P. M., Zhao, Y., Li, M., Chen, H.-R., Kowalski, J., … Dong, J.-T. (2021). Acetylation of KLF5 maintains EMT and tumorigenicity to cause chemoresistant bone metastasis in prostate cancer. Nature Communications, 12(1), 1714. https://doi.org/10.1038/s41467-021-21976-w Cite
Full Article
Exit mobile version